Per‐ and Polyfluoroalkyl Substances and Hand Osteoarthritis: Data From the Osteoarthritis Initiative
Arthritis & Rheumatology · 2026
DOI: 10.1002/art.70026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2026. Verfasst von Jeffrey B Driban und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, Massachusetts. Hauptthemen laut MEDLINE: Osteoarthritis, Fluorocarbons, Hand Joints. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIAMS NIH HHS, NIEHS NIH HHS.
Abstract (Originalsprache)
Objective
To explore whether biologic levels of specific per‐ and polyfluoroalkyl substances (PFAS) and a mixture of PFAS—reflecting the overall effect and accounting for correlations among PFAS—relate to incident hand osteoarthritis (HOA) and progression.
Methods
Among a case‐cohort sample from the Osteoarthritis Initiative (n = 1,878), we examined associations of eight PFAS in serum with odds of developing over the subsequent 4 years (1) symptomatic HOA and (2) an increased number of joints with radiographic osteoarthritis (Kellgren‐Lawrence ≥2; yes/no). We used weighted logistic regression to assess single PFAS (continuous and quartiles) and quantile g‐computation to assess the PFAS mixture in relation to our primary outcomes.
Results
Participants were primarily female (58%) and on average aged 62 years and overweight (mean body mass index = 28.6 kg/m 2 ). Participants with higher perfluorodecanoic acid (PFDA) and perfluorononanoic acid (PFNA; continuous variables) had greater odds of incident symptomatic HOA (odds ratio [OR] [95% confidence interval (CI)] per interquartile range increment: PFDA 1.12 [1.05–1.20]; PFNA 1.07 [1.00–1.13]), but associations were not monotonic when these PFAS were represented in quartiles. Participants with higher perfluorohexane sulfonic acid had lower odds of incident HOA (eg, OR 0.94 [95% CI 0.88–1.00] per interquartile range increment). We observed no other consistent associations between PFAS and either outcome.
Conclusion
We observed possible associations of PFDA and PFNA serum concentrations with symptomatic HOA incidence, but we otherwise found no consistent evidence that greater PFAS concentrations relate to a greater chance of developing HOA incidence or progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, Massachusetts.
- Center for Interdisciplinary and Population Health Research, MaineHealth Institute for Research, Westbrook, Maine.
- Department of Public Health Sciences, UConn Health, Farmington, Connecticut.
- Division of Rheumatology, Department of Medicine, UMass Chan Medical School, Worcester, Massachusetts.
- Center for Primary Care and Prevention, Kent Hospital, Pawtucket, Rhode Island.
- Department of Family Medicine, Warren Alpert Medical School Brown University, Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island.
ORCID-Profile: Jeffrey B Driban, Charles B Eaton, Ida K Haugen
Förderung
- NIH HHS
- NIAMS NIH HHS
- NIEHS NIH HHS
- National Institute of Environmental Health Sciences
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institutes of Health
Zitieren
APA
Driban, J. B., Rokoff, L. B., Lu, B., McAlindon, T. E., Eaton, C. B., Roberts, M. B., Mathes, D., Lestician, C., Xu, Z. C., Fan, Z. T., O'Leary, S. P., Haugen, I. K., Sellam, J., Courties, A., & Fleisch, A. F. (2026). Per‐ and Polyfluoroalkyl Substances and Hand Osteoarthritis: Data From the Osteoarthritis Initiative. Arthritis & Rheumatology. https://doi.org/10.1002/art.70026
Vancouver
Driban JB, Rokoff LB, Lu B, McAlindon TE, Eaton CB, Roberts MB, et al. Per‐ and Polyfluoroalkyl Substances and Hand Osteoarthritis: Data From the Osteoarthritis Initiative. Arthritis & Rheumatology. 2026. doi:10.1002/art.70026
BibTeX
@article{Driban2026,
author = {Driban, Jeffrey B and Rokoff, Lisa B and Lu, Bing and McAlindon, Timothy E and Eaton, Charles B and Roberts, Mary B and Mathes, Diana and Lestician, Colleen and Xu, Zhijin Carrie and Fan, Zhihua Tina and O'Leary, Shawn P and Haugen, Ida K and Sellam, Jérémie and Courties, Alice and Fleisch, Abby F},
title = {Per‐ and Polyfluoroalkyl Substances and Hand Osteoarthritis: Data From the Osteoarthritis Initiative},
journal = {Arthritis & Rheumatology},
year = {2026},
doi = {10.1002/art.70026}
}
EUVIMED